Logo image of AIRS

AIRSCULPT TECHNOLOGIES INC (AIRS) Stock Fundamental Analysis

NASDAQ:AIRS - Nasdaq - US0094961002 - Common Stock - Currency: USD

4.55  -0.7 (-13.33%)

After market: 4.57 +0.02 (+0.44%)

Fundamental Rating

2

Overall AIRS gets a fundamental rating of 2 out of 10. We evaluated AIRS against 102 industry peers in the Health Care Providers & Services industry. AIRS may be in some trouble as it scores bad on both profitability and health. AIRS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year AIRS has reported negative net income.
AIRS had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AIRS reported negative net income in multiple years.
In the past 5 years AIRS always reported a positive cash flow from operatings.
AIRS Yearly Net Income VS EBIT VS OCF VS FCFAIRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

AIRS's Return On Assets of -8.43% is on the low side compared to the rest of the industry. AIRS is outperformed by 74.51% of its industry peers.
AIRS's Return On Equity of -22.15% is on the low side compared to the rest of the industry. AIRS is outperformed by 64.71% of its industry peers.
Industry RankSector Rank
ROA -8.43%
ROE -22.15%
ROIC N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
AIRS Yearly ROA, ROE, ROICAIRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Gross Margin of AIRS (63.75%) is better than 86.27% of its industry peers.
AIRS's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AIRS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
AIRS Yearly Profit, Operating, Gross MarginsAIRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40 60

0

2. Health

2.1 Basic Checks

AIRS does not have a ROIC to compare to the WACC, probably because it is not profitable.
AIRS has more shares outstanding than it did 1 year ago.
AIRS has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AIRS is higher compared to a year ago.
AIRS Yearly Shares OutstandingAIRS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AIRS Yearly Total Debt VS Total AssetsAIRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 1.61, we must say that AIRS is in the distress zone and has some risk of bankruptcy.
AIRS has a Altman-Z score of 1.61. This is in the lower half of the industry: AIRS underperforms 60.78% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that AIRS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.90, AIRS perfoms like the industry average, outperforming 40.20% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Altman-Z 1.61
ROIC/WACCN/A
WACC8.6%
AIRS Yearly LT Debt VS Equity VS FCFAIRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

A Current Ratio of 0.57 indicates that AIRS may have some problems paying its short term obligations.
AIRS has a Current ratio of 0.57. This is amonst the worse of the industry: AIRS underperforms 88.24% of its industry peers.
A Quick Ratio of 0.57 indicates that AIRS may have some problems paying its short term obligations.
AIRS has a worse Quick ratio (0.57) than 82.35% of its industry peers.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57
AIRS Yearly Current Assets VS Current LiabilitesAIRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

4

3. Growth

3.1 Past

AIRS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1450.00%.
AIRS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.96%.
The Revenue has been growing by 34.35% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120%
Revenue 1Y (TTM)-12.96%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.32%

3.2 Future

AIRS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.51% yearly.
Based on estimates for the next years, AIRS will show a small growth in Revenue. The Revenue will grow by 3.40% on average per year.
EPS Next Y-13.9%
EPS Next 2Y8.81%
EPS Next 3Y25.51%
EPS Next 5YN/A
Revenue Next Year-11.68%
Revenue Next 2Y-3.75%
Revenue Next 3Y1.04%
Revenue Next 5Y3.4%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AIRS Yearly Revenue VS EstimatesAIRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
AIRS Yearly EPS VS EstimatesAIRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2 0.3

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AIRS. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AIRS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AIRS Price Earnings VS Forward Price EarningsAIRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AIRS Per share dataAIRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as AIRS's earnings are expected to grow with 25.51% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y8.81%
EPS Next 3Y25.51%

0

5. Dividend

5.1 Amount

No dividends for AIRS!.
Industry RankSector Rank
Dividend Yield N/A

AIRSCULPT TECHNOLOGIES INC

NASDAQ:AIRS (6/13/2025, 8:00:00 PM)

After market: 4.57 +0.02 (+0.44%)

4.55

-0.7 (-13.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-02 2025-05-02/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners23.54%
Inst Owner Change1.19%
Ins Owners27.78%
Ins Owner Change4.94%
Market Cap267.45M
Analysts76
Price Target3.83 (-15.82%)
Short Float %52.44%
Short Ratio14.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP-1.4%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.16%
Min EPS beat(2)-103.64%
Max EPS beat(2)67.32%
EPS beat(4)1
Avg EPS beat(4)-94.56%
Min EPS beat(4)-245.86%
Max EPS beat(4)67.32%
EPS beat(8)2
Avg EPS beat(8)-45.64%
EPS beat(12)4
Avg EPS beat(12)-94.4%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.56%
Min Revenue beat(2)-11.47%
Max Revenue beat(2)-1.64%
Revenue beat(4)0
Avg Revenue beat(4)-5.67%
Min Revenue beat(4)-11.47%
Max Revenue beat(4)-0.03%
Revenue beat(8)1
Avg Revenue beat(8)-3.77%
Revenue beat(12)3
Avg Revenue beat(12)-2.61%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)12.5%
PT rev (3m)-45.12%
EPS NQ rev (1m)51.53%
EPS NQ rev (3m)-139.99%
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-0.8%
Revenue NQ rev (3m)-19.2%
Revenue NY rev (1m)-0.39%
Revenue NY rev (3m)-19.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.55
P/FCF N/A
P/OCF 30.21
P/B 3.46
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.15
OCFY3.31%
SpS2.93
BVpS1.32
TBVpS-0.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.43%
ROE -22.15%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.75%
FCFM N/A
ROA(3y)-4.48%
ROA(5y)-0.79%
ROE(3y)-12.17%
ROE(5y)-3.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.45%
GM growth 5Y-0.58%
F-Score2
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 116.4%
Cap/Sales 8.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z 1.61
F-Score2
WACC8.6%
ROIC/WACCN/A
Cap/Depr(3y)124.96%
Cap/Depr(5y)109.63%
Cap/Sales(3y)6.83%
Cap/Sales(5y)6.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1450%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120%
EPS Next Y-13.9%
EPS Next 2Y8.81%
EPS Next 3Y25.51%
EPS Next 5YN/A
Revenue 1Y (TTM)-12.96%
Revenue growth 3Y10.6%
Revenue growth 5Y34.35%
Sales Q2Q%-17.32%
Revenue Next Year-11.68%
Revenue Next 2Y-3.75%
Revenue Next 3Y1.04%
Revenue Next 5Y3.4%
EBIT growth 1Y-177.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.19%
EBIT Next 3Y27.11%
EBIT Next 5YN/A
FCF growth 1Y-149.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-62.47%
OCF growth 3Y-24.74%
OCF growth 5Y18.1%